Recursion Pharmaceuticals (NASDAQ: RXRX), a biotech focused on artificial intelligence (AI), became a publicly traded company ...

While Recursion Pharmaceuticals has struggled for traction this year, the elevated short interest of RXRX stock and a key ...

Recursive digital selves underpin targeted advertising, predictive policing, and workplace monitoring. In each case, the ...

For one thing, BigBear.ai's revenue plunged 18% year over year in the second quarter of 2025. While Diebold Nixdorf's revenue also fell, the decline was only 2.6%. Importantly, the company's revenue ...

The CPG marketer, in partnership with data firm Vidmob, found that predictive impact scoring can boost creative performance ...

Criminal groups are leveraging AI to generate polymorphic malware such as Black Mamba, which mutates to evade detection. The ...

Nvidia’s announcement earlier this week that it is investing $100 billion into OpenAI to help fund its massive data center ...

From AI-powered insurance bots to drug discovery platforms, these overlooked stocks offer pure-play exposure to artificial intelligence without trillion-dollar valuations.

Beginning in 2022, EarthtoStar co-ran a bustling Telegram channel called Star Chat, which was home to a prolific SIM-swapping ...

Recursion Pharmaceuticals (RXRX) ended the recent trading session at $4.98, demonstrating a +1.32% change from the preceding day's closing price. The stock's change was more than the S&P 500's daily ...

Vancouver company uses generative AI to identify potential molecules, saving millions of dollars and months compared to other ...

Through my research collaboration with design scholar Ron Eglash, author of “ African Fractals ,” I discovered that the design style that undergirds much of the graphic design profession today – the ...